Pharma-Bio Serv (PBSV) EBT Margin (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly EBT Margin came in at 8.86% in Q2 2026, up 468.0% on a YoY basis from 1.56% in Q2 2025, and up 456.93% quarter-over-quarter from 1.59% in Q1 2026.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) EBT Margin (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported EBT Margin for 16 consecutive years, with 8.86% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 468.0% year-over-year to 8.86%; the trailing twelve-month figure through Apr 2026 stood at 0.78% (up 280.0% YoY), and the FY2025 full-year result was 1.05%, up 690.0% from the prior year.
- EBT Margin rose to 8.86% in Q2 2026 per PBSV's latest filing, from 1.59% in the prior quarter.
- Across five years, EBT Margin topped out at 13.57% in Q1 2023 and bottomed at 12.0% in Q3 2024.
- Historically, EBT Margin has averaged 1.95% across 5 years, with a median of 2.88% in 2025.
- The widest YoY moves for EBT Margin: up 9068 bps in 2022, down 3976 bps in 2022.
- Over 5 years, EBT Margin stood at 4.98% in 2022, then plunged by 127 bps to 1.33% in 2023, then jumped by 52 bps to 0.64% in 2024, then surged by 131 bps to 0.2% in 2025, then jumped by 4375 bps to 8.86% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 8.86%, 1.59%, and 0.2% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 16.83% |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 41.42% |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 21.16% |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 11.52% |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 8.96% |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 14.21% |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 13.39% |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | 7.35% |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 23.05% |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 8.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 8.86% |
| Jan 31, 2026 | 1.59% |
| Oct 31, 2025 | 0.20% |
| Jul 31, 2025 | -10.65% |
| Apr 30, 2025 | 4.17% |
| Jan 31, 2025 | 0.39% |
| Oct 31, 2024 | -0.64% |
| Jul 31, 2024 | -12.00% |
| Apr 30, 2024 | -8.10% |
| Jan 31, 2024 | -10.83% |
| Oct 31, 2023 | -1.33% |
| Jul 31, 2023 | 12.83% |
| Apr 30, 2023 | 12.55% |
| Jan 31, 2023 | 13.57% |
| Oct 31, 2022 | 4.98% |
| Jul 31, 2022 | 6.62% |
| Apr 30, 2022 | 5.74% |
| Jan 31, 2022 | 7.10% |
| Oct 31, 2021 | -85.70% |
| Jul 31, 2021 | 46.38% |